The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASLR.L Regulatory News (ASLR)

  • There is currently no data for ASLR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes

23 Sep 2020 15:24

RNS Number : 9163Z
Asimilar Group PLC
23 September 2020
 

23 September 2020

 

 

ASIMILAR GROUP PLC ('ASIMILAR' OR 'THE COMPANY')

 

Board Changes

 

Asimilar Group plc (AIM: ASLR), the AIM quoted investment company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT), is pleased to announce that, further to the announcement made on 1 September 2020, Mark Horrocks has been appointed to the Board of Asimilar as a Non-Executive Director with immediate effect.

 

Donald Stewart, a director of the Company, will retire from the Board to pursue his other commercial interests. His resignation will take effect from the conclusion of the forthcoming Annual General Meeting, the date of which will be announced by the Company in the coming days.

 

The Board has also begun a search to identify a further independent Non-Executive Director and is committed to appointing such an individual on completion of relevant due diligence processes. The Company will update the market on progress in this regard in due course.

 

Mark Horrocks has over 37 years' experience in financial markets and has been involved mainly in large scale institutional fund management. He has worked as a research analyst and fund manager for a FTSE100 insurance group. In addition, he has always maintained a keen interest in supporting smaller companies and identifying nascent opportunities as investor and supporting as mentor and, on occasion, board member. In 1997 Mark co-founded Intrinsic Capital Partnership Limited, in order to self-manage the Intrinsic Value PLC Investment Trust, an investor in mainly small/micro capitalized quoted companies. Mark then established Intrinsic Capital LLP in 2007 as a regulated corporate and introductory business and extended the regulatory permission to include a retail investment management offering in 2015 seeking to add value with a straightforward, transparent and cost-efficient service to high net worth and professional investors.

 

Mark Ian Horrocks (age 58) holds or has held in the past five years the following directorships and/or partnerships:

 

Current

Past

17 and 18 Three Yard Limited

CDialogues plc

Concha Limited

Dean Art Investments Limited

Dewscope Limited

Echo Digital Limited

Immedia Group plc

Interactive Investor Limited

Intrinsic Capital LLP

Intrinsic Value Limited

Intrinsic Capital Services Limited

Intrinsic Value Partnership Limited

Leander Ventures Limited

Money Dashboard Limited

Marshdale Properties Limited

Open Golf and Leisure Limited

Ritorno plc

Mr Horrocks was a director of Ballymore Leisure Limited when a receiver was appointed in April 2003.

Mr Horrocks was a director of Envenio Limited when it was subject to a creditors' voluntary liquidation in June 2008.

Mr Horrocks was a director of Technomark Consulting Services Limited when it was dissolved pursuant to a winding up order in June 2011.

Mr Horrocks was a director of Biopharm Knowledge Publishing Limited when it was subject to a creditors' voluntary liquidation in August 2012.

Mark Horrocks, his related parties and other members of his family have an interest in 5,422,947 Asimilar ordinary shares, representing 5.10% of Asimilar's issued share capital. In addition Mark Horrocks has warrants to subscribe for up to 9,000,000 Asimilar ordinary shares in 2 tranches of up to 4,500,000 warrants per tranche. Each tranche will be exercisable for two years after the relevant price criteria having been reached. The relevant price criteria are the mid-market closing price of shares in Dev Clever Holdings plc for a period of five consecutive Business Days being or exceeding (i) 28 pence; and (ii) 55 pence respectively.

There is no further information to be disclosed in relation to Mark Horrock's appointment pursuant to AIM Rule 17 or Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies.

 

-Ends-

Contacts

Asimilar Group plc

John Taylor, Non-Executive Chairman

via Buchanan

Cairn Financial Advisers LLP

Sandy Jamieson / Liam Murray

Tel: +44 20 7213 0880

Peterhouse Capital Limited

Duncan Vasey / Lucy Williams

Tel: + 44 20 7220 9797

Buchanan Communications Limited

Richard Oldworth / Chris Lane

Tel: +44 (0) 20 7466 5000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKKNBBQBKDNCB
Date   Source Headline
1st Apr 20213:58 pmRNSExercise of Warrants
31st Mar 20216:04 pmRNSExtension of Warrant Exercise Date
30th Mar 20217:00 amRNSAnnual Report and Accounts and Portfolio Update
29th Mar 20215:32 pmRNSExercise of Warrants & Vesting of Warrants
26th Mar 20213:36 pmRNSExercise of Warrants
22nd Mar 20211:17 pmRNSHolding(s) in Company
18th Mar 20217:00 amRNSCompletion of Subscription
9th Mar 20212:06 pmRNSUpdate re MESH
1st Mar 202111:02 amRNSDev Clever Subscription
25th Feb 20217:00 amRNSAssignment of Subscription Rights
17th Feb 20214:29 pmRNSExercise of Warrants
15th Feb 202111:35 amRNSAnnouncement of Agreement by MESH re Sentiance
27th Jan 20217:00 amRNSUpdate re: Dev Clever Subscription Rights
26th Jan 20217:00 amRNSUpdate re subscription in Dev Clever
18th Jan 20219:51 amRNSExercise of Warrants
13th Jan 20218:28 amRNSExercise of Warrants
12th Jan 20214:41 pmRNSSecond Price Monitoring Extn
12th Jan 20214:35 pmRNSPrice Monitoring Extension
31st Dec 20207:00 amRNSFurther Equity Investment in SeeQuestor
21st Dec 20207:30 amRNSStatement re Announcement by Dev Clever
17th Dec 20207:00 amRNSDirector's Disclosure
7th Dec 20207:00 amRNSFurther Investment in Magic Media Works
1st Dec 20207:00 amRNSFurther conditional investment in Dev Clever
30th Nov 20204:08 pmRNSAssignment of Sentiance Loan
24th Nov 20207:00 amRNSDirector's Dealing
9th Nov 20202:49 pmRNSUpdate re Magic Media Works Limited
9th Nov 20207:00 amRNSFurther Investment in SeeQuestor
2nd Nov 20207:00 amRNSUpdate re Dev Clever Subscription Rights
26th Oct 202011:21 amRNSResult of AGM
23rd Oct 20207:00 amRNSExercise of Warrants
20th Oct 20207:00 amRNSAward of Warrants to Director
7th Oct 20204:40 pmRNSSecond Price Monitoring Extn
7th Oct 20204:35 pmRNSPrice Monitoring Extension
7th Oct 20202:05 pmRNSSecond Price Monitoring Extn
7th Oct 20202:00 pmRNSPrice Monitoring Extension
30th Sep 20207:00 amRNSNotice of AGM & Update re Loan to Sentiance
29th Sep 20203:18 pmRNSHolding(s) in Company
23rd Sep 20203:24 pmRNSBoard Changes
16th Sep 202012:57 pmRNSExercise of Warrants
10th Sep 202012:00 pmRNSUpdate re: Dev Clever Holdings plc
8th Sep 20202:39 pmRNSMarket Update
7th Sep 20207:00 amRNSHolding(s) in Company
3rd Sep 20207:00 amRNSExercise of Subscription rights
1st Sep 20207:00 amRNSAcquisition of Intrinsic Capital (Jersey) Ltd
1st Sep 20207:00 amRNSUpdate to Right to Subscribe
25th Aug 20207:30 amRNSRestoration - Asimilar Group plc
25th Aug 20207:00 amRNSCompletion of Agreement & Lifting of Suspension
20th Aug 202011:29 amRNSMESH AGM
3rd Aug 20203:12 pmRNSAgreement with MESH Holdings plc
31st Jul 202012:14 pmRNSUpdate re. Suspension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.